Tesi Raymond Joseph - Mar 21, 2022 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Signature
/s/ Raymond Joseph Tesi
Stock symbol
INMB
Transactions as of
Mar 21, 2022
Transactions value $
$199,993
Form type
4
Date filed
3/23/2022, 04:33 PM
Previous filing
Nov 4, 2021
Next filing
May 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INMB Common Stock Award $200K +23.7K +1.59% $8.43 1.51M Mar 22, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Option (right to buy) Award $0 +130K $0.00 130K Mar 21, 2022 Common Stock 130K $7.92 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase price of the common stock being reported is the closing price per share immediately preceding the entering into of the binding agreement to issue the securities . These shares were purchased by the Reporting Person directly from Issuer.
F2 Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.